$-0.44
(Market cap
$0 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-5 Mln
-
ROE
-1.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.5
-
Debt to Equity
0.1
-
Book Value
$4
-
EPS
$-10.4
-
Face value
--
-
Shares outstanding
1,135,358
10 Years Aggregate
CFO
$-169.25 Mln
EBITDA
$-211.33 Mln
Net Profit
$-161.97 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ampio Pharm (AMPE)
| -- | -- | -- | -- | -68.4 | -79.7 | -58.3 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Ampio Pharm (AMPE)
| -54.5 | -97.3 | -64.2 | 172.7 | 47.7 | -90.2 | 352.1 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Ampio Pharm (AMPE)
|
0.2 | 0.2 | 0.0 | -8.6 | -3,784.9 | -114 | -- | 0.1 |
| 7.5 | 14.8 | 5.7 | -13.9 | -346.0 | -86.8 | -- | 0.8 | |
| 1.2 | 51.9 | 2.5 | 522.6 | -188.5 | 744.1 | -- | 0.2 |
Shareholding Pattern
View DetailsAbout Ampio Pharm (AMPE)
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment... of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado. Read more
-
CEO & Director
Mr. Michael A. Martino
-
CEO, CFO, General Secretary & Director
Mr. Michael A. Martino
-
Headquarters
Englewood, CO
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Ampio Pharm (AMPE)
What is the current share price of Ampio Pharm (AMPE) Today?
The share price of Ampio Pharm (AMPE) is $0.18 (NYSE) as of 05-Jun-2026 09:30 EDT. Ampio Pharm (AMPE) has given a return of -68.4% in the last 3 years.
What is the current PB & PE ratio of Ampio Pharm (AMPE)?
Since, TTM earnings of Ampio Pharm (AMPE) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-0.20 |
0.51 |
2022 |
-0.01 |
0.01 |
2021 |
-0.02 |
0.01 |
2020 |
-0.06 |
0.06 |
2019 |
-0.02 |
0.05 |
What is the 52 Week High and Low of Ampio Pharm (AMPE)?
The 52-week high and low of Ampio Pharm (AMPE) are Rs 0.18 and Rs 0.18 as of 30-Aug-2026.
What is the market cap of Ampio Pharm (AMPE)?
Ampio Pharm (AMPE) has a market capitalisation of $ 0 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Ampio Pharm (AMPE)?
Before investing in Ampio Pharm (AMPE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.